Skip to main content

GT is sponsoring the 31st Annual Conference on Drug & Medical Device Litigation, taking place on December 2-3 in New York. A leading forum for the pharmaceutical and medical device litigation community, the conference will bring together hundreds of litigators, in-house counsel, and members of the judiciary to examine emerging developments, share practical strategies, and connect with peers across the industry.

GT attorneys will play an active role throughout the two-day program. Conference Co-Chair Marcella Ducca will deliver opening remarks on the first day, followed by Cliff Merrell’s participation in “The Latest Developments in Third-Party Litigation Funding: Managing Risk and Reclaiming Control Amid Rapid Expansion and Limited Transparency,” examining the growing influence of third-party litigation funding on litigation and settlement strategy and the evolving regulatory landscape.

On day two, Jack Frost will join “Labeled as Carcinogens, Litigated as Cause: Building the Defense in Trace-Exposure Cancer Claims,” a discussion of science-driven and fact-specific defense strategies for claims involving alleged low-level exposure to labeled carcinogens. Lori Cohen will participate in “Holding Hands Across the So-Called ‘Enemy’ Lines: A Historic Dialogue with Leading Plaintiffs’ Counsel,” bringing together leading defense and plaintiffs’ counsel for a candid discussion of opportunities to create a more efficient litigation ecosystem.